Murni Marlina Abd Karim

Dr. Murni Marlina Abd Karim

Department of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia (UPM)
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2016 in BMC Microbiology
Verified
Journal Article
Open access
PDF file
WZWenjing Zhao
Wenjing Zhao
CDChristine Dao
Christine Dao
MKMurni Marlina Abd Karim
Murni Marlina Abd Karim
MGMarta Gomez-Chiarri
Marta Gomez-Chiarri
DRDavid Rowley
David Rowley
DNDavid R. Nelson
David R. Nelson
The probiotic bacterium Phaeobacter inhibens strain S4Sm, isolated from the inner shell surface of a healthy oyster, secretes the antibiotic tropodithietic acid (TDA), is an excellent biofilm former, and increases oyster larvae survival when challenged with bacterial pathogens. In this study, we investigated the specific roles of TDA secretion and biofilm formation in the probiotic activity of S4Sm. Mutations in clpX (ATP-dependent ATPase) and exoP (an exopolysaccharide biosynthesis gene) were created by insertional mutagenesis using homologous recombination. Mutation of clpX resulted in the loss of TDA production, no decline in biofilm formation, and loss of the ability to inhibit the growth of Vibrio tubiashii and Vibrio anguillarum in co-colonization experiments. Mutation of exoP resulted in a ~60 % decline in biofilm formation, no decline in TDA production, and delayed inhibitory activity towards Vibrio pathogens in co-colonization experiments. Both clpX and exoP mutants exhibited reduced ability to protect oyster larvae from death when challenged by Vibrio tubiashii. Complementation of the clpX and exoP mutations restored the wild type phenotype. We also found that pre-colonization of surfaces by S4Sm was critical for this bacterium to inhibit pathogen colonization and growth. Our observations demonstrate that probiotic activity by P. inhibens S4Sm involves contributions from both biofilm formation and the production of the antibiotic TDA. Further, probiotic activity also requires colonization of surfaces by S4Sm prior to the introduction of the pathogen.

6 January 2022 in Materials
Verified
Journal Article
Open access
ANAshwini Naganthran
Ashwini Naganthran
GVGayathiri Verasoundarapandian
Gayathiri Verasoundarapandian
FKFarah Eryssa Binti Ahmad Saiful Khalid
Farah Eryssa Binti Ahmad Saiful Khalid
MMMas Jaffri Masarudin
Mas Jaffri Masarudin
Azham ZulkharnainAzham Zulkharnain
Azham Zulkharnain
Siti Aqlima AhmadSiti Aqlima Ahmad
Siti Aqlima Ahmad
Silver nanoparticles (AgNPs) have been employed in various fields of biotechnology due to their proven properties as an antibacterial, antiviral and antifungal agent. AgNPs are generally synthesized through chemical, physical and biological approaches involving a myriad of methods. As each approach confers unique advantages and challenges, a trends analysis of literature for the AgNPs synthesis using different types of synthesis were also reviewed through a bibliometric approach. A sum of 10,278 publications were analyzed on the annual numbers of publication relating to AgNPs and biological, chemical or physical synthesis from 2010 to 2020 using Microsoft Excel applied to the Scopus publication database. Furthermore, another bibliometric clustering and mapping software were used to study the occurrences of author keywords on the biomedical applications of biosynthesized AgNPs and a total collection of 224 documents were found, sourced from articles, reviews, book chapters, conference papers and reviews. AgNPs provides an excellent, dependable, and effective solution for seven major concerns: as antibacterial, antiviral, anticancer, bone healing, bone cement, dental applications and wound healing. In recent years, AgNPs have been employed in biomedical sector due to their antibacterial, antiviral and anticancer properties. This review discussed on the types of synthesis, how AgNPs are characterized and their applications in biomedical field.

17 March 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Mohamad Syazwan NgalimatMohamad Syazwan Ngalimat
Mohamad Syazwan Ngalimat
RYRadin Shafierul Radin Yahaya
Radin Shafierul Radin Yahaya
MBMohamad Malik Al-Adil Baharudin
Mohamad Malik Al-Adil Baharudin
SYSyafiqah Mohd. Yaminudin
Syafiqah Mohd. Yaminudin
MKMurni Marlina Abd Karim
Murni Marlina Abd Karim
Suriana SabriSuriana Sabri
Suriana Sabri
Bacteria under the operational group Bacillus amyloliquefaciens (OGBa) are all Gram-positive, endospore-forming, and rod-shaped. Taxonomically, the OGBa belongs to the Bacillus subtilis species complex, family Bacillaceae, class Bacilli, and phylum Firmicutes. To date, the OGBa comprises four bacterial species: Bacillus amyloliquefaciens, Bacillus siamensis, Bacillus velezensis and Bacillus nakamurai. They are widely distributed in various niches including soil, plants, food, and water. A resurgence in genome mining has caused an increased focus on the biotechnological applications of bacterial species belonging to the OGBa. The members of OGBa are known as plant growth-promoting bacteria (PGPB) due to their abilities to fix nitrogen, solubilize phosphate, and produce siderophore and phytohormones, as well as antimicrobial compounds. Moreover, they are also reported to produce various enzymes including α-amylase, protease, lipase, cellulase, xylanase, pectinase, aminotransferase, barnase, peroxidase, and laccase. Antimicrobial compounds that able to inhibit the growth of pathogens including non-ribosomal peptides and polyketides are also produced by these bacteria. Within the OGBa, various B. velezensis strains are promising for use as probiotics for animals and fishes. Genome mining has revealed the potential applications of members of OGBa for removing organophosphorus (OPs) pesticides. Thus, this review focused on the applicability of members of OGBa as plant growth promoters, biocontrol agents, probiotics, bioremediation agents, as well as producers of commercial enzymes and antibiotics. Here, the bioformulations and commercial products available based on these bacteria are also highlighted. This review will better facilitate understandings of members of OGBa and their biotechnological applications.

21 December 2020 in Animals
Verified
Journal Article
Open access
PDF file
NSNur Amalina Samat
Nur Amalina Samat
F.M. YusoffF.M. Yusoff
F.M. Yusoff
NRNadiah Wan Rasdi
Nadiah Wan Rasdi
MKMurni Marlina Abd Karim
Murni Marlina Abd Karim
At the present time, no artificial larval diet is capable of entirely fulfilling the dietary requirements of several larval fish and crustacean species. Zooplankton live food is the basic foundation of fish larviculture, and successful rearing of fish larvae still heavily depends on an adequate supply of nutritious live food. Despite being important, the production protocols of copepods and cladocerans (Moina) are still underdeveloped in hatcheries. Rotifers and Artemia are the most commonly used live foods. However, these live foods are evidently lacking in crucial nutrient constituents. Hence, through nutrient enrichment, live food with the nutritional profile that meets the requirements of fish larvae can be produced. With the aim to maximize the effectiveness of production to optimize profitability, it is important to evaluate and improve culture techniques for the delivery of micro- and macro-nutrients as feed supplements to larvae in aquaculture systems. Bioencapsulation and enrichment are the evolving techniques in aquaculture that are commonly employed to enhance the nutritional quality of live food by integrating nutrients into them, which subsequently improves the growth, survival, and disease resistance of the consuming hosts. This review aims to highlight some of the approaches and methods used to improve the nutritional quality of live food by modifying their nutrient composition, which could have immense promise in the enhancement of aquatic animal health.

1 January 2018 in Aquaculture
Verified
Journal Article
Closed access
ADAkeem Babatunde Dauda
Akeem Babatunde Dauda
NRNicholas Romano
Nicholas Romano
MEMahdi Ebrahimi
Mahdi Ebrahimi
JTJun Chin Teh
Jun Chin Teh
AAAbdullateef Ajadi
Abdullateef Ajadi
MKMohd Salleh Kamarudin
Mohd Salleh Kamarudin

1 August 2013 in Journal of Shellfish Research
Verified
Journal Article
Closed access
MKMurni Marlina Abd Karim
Murni Marlina Abd Karim
WZWenjing Zhao
Wenjing Zhao
DRDavid Rowley
David Rowley
DNDavid Nelson
David Nelson
MGMarta Gomez-Chiarri
Marta Gomez-Chiarri
Bacterial pathogens, including several Vibrio spp. and Roseovarius crassostreae, cause severe mortality of larval and juvenile eastern oysters. The introduction of beneficial bacterial isolates in oyster hatcheries and nurseries for the biocontrol of bacterial diseases is a good alternative to the use of antibiotics. The goal of this study was to screen and characterize marine bacterial isolates as potential agents to prevent larval and juvenile mortality by the oyster pathogens Vibrio tubiashii and R. crassostreae. Screening of bacterial isolates from Rhode Island marine organisms and environment using agar-based assay methods for detection of antimicrobial activity against oyster pathogens led to the isolation of candidate probionts Phaeobacter sp. S4 and Bacillus pumilus RI06-95. Pretreatment of larval and juvenile oysters for 24 h with 102–106 cfu/mL Phaeobacter sp. S4 or B. pumilus RI06-95 protected larval oysters against mortality resulting from challenge with R. crassostreae and V. tubiash...